SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
We present a new case of bacterial spontaneous peritonitis cirrhosis, associated to an extremely rare germ as it is Pasteurella multocida. We describe its clinical characteristics and evolution after treatment.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Three commercially available adjuvants--incomplete Freund's, Ribi adjuvant system, and Hunter's TiterMax--were used to compare antibody responses of broilers to Pasteurella multocida antigen. Differences among treatments over the 9-week study were determined by measuring antibody responses of twice-vaccinated birds using an enzyme-linked immunoassay. The antibody level induced by the vaccine with incomplete Freund's adjuvant was the highest, followed by the vaccines with TiterMax and Ribi.
For the first time in Cameroon, a strain of Pasteurella multocida serotype B6 was isolated from a haemorrhagic septicaemia outbreak in Zebu cattle in the area of Maga (Far Northern Province). Through the mouse protection test, evidence was given that there was no cross protection between this strain and the strain of Pasteurella multocida serotype E6 which is used as an inactivated vaccine in Cameroon. Hence, it is recommended to use a combined vaccine including both serotypes for the Central and West African countries.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The diseases, lesions, congenital disorders, and parasites of both Insectivora and prosimian shrews were reviewed. Preliminary baseline data provide encouraging prospects for using these animals as research models because few spontaneous diseases and lesions have been reported. It must be pointed out, however, that throughout the literature reviewed, clinical histories were incomplete and histopathologic examinations had seldom been performed, particularly with the parasitic entities.
A challenge-exposure model was developed for dose-dependent induction of subclinical (moderate) atrophic rhinitis (AR) in conventionally raised Dutch Landrace and Large White pigs, about 4 weeks old. Under favorable climatic and housing conditions, pigs were intranasally challenge-exposed with Pasteurella multocida-derived toxin (Pm-T) 3 days after pretreatment by inoculation with 1% acetic acid. Pigs were challenge-exposed with 1 of the following Pm-T doses: 0 (control), 5, 13, 20, or 40 micrograms of Pm-T/ml of phosphate-buffered saline solution (PBSS), 0.5 ml/nostril/d on 3 consecutive days. Five weeks after challenge exposure, subclinical (moderate) AR status was defined as intermediate conchal atrophy (grade 2 for ventral conchae on a 0 to 4 scale and grade 1 or 2 for dorsal conchae on a 0 to 3 scale, respectively) and perceptible difference in change in brachygnathia superior (cBS) between control and challenge-exposed pigs between the beginning and end of the study. All Pm-T-exposed pigs had nasal damage that was dose-dependent. The higher Pm-T doses resulted in higher ventral conchae atrophy and dorsal conchae atrophy scores. The cBS increased with applied Pm-T dose, resulting in significant (P < 0.05) differences between controls (3.88 mm) and the 13-, 20-, and 40-micrograms Pm-T-treated groups (7.77, 6.58, and 7.98 mm, respectively). In response to the applied dose, weight gain per week for Pm-T-exposed pigs was lower than that of controls after week 3 (P < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
Strains X-73 (serotype 1) and P-1059 (serotype 3) of Pasteurella multocida, avian origin, expressed additional membrane proteins (MPs) when grown in brain-heart infusion (BHI) broth containing the iron chelator dipyridyl and when grown in BHI broth treated with the iron chelator Chelex 100. These additional MPs were not detected when both strains were grown in BHI broth. Chickens and turkeys were vaccinated twice with inactivated oil-emulsion vaccines containing bacterial cells expressing these MPs or with vaccines containing bacterial cells grown in BHI broth. Two weeks after the final vaccination, all birds were challenged to determine whether bacterins made from P. multocida that had been propagated in conditions of iron deprivation would induce heterologous serotype immunity. The bacterins produced in medium low in iron did not consistently induce significant protection against heterologous challenge.
Severe cephalic swelling and facial cellulitis in turkeys associated with fowl cholera were present in seven accessions submitted to two laboratories in a 2-year period. Flocks ranged in age from 6 to 18 weeks and included both toms and hens. Interestingly, turkeys with facial cellulitis had no gross internal lesions of fowl cholera, whereas birds with gross lung, liver, and air-sac lesions did not have swollen heads. Histologically, the facial cellulitis was characterized by extensive fibrinonecrotic inflammation of the deep dermis with heterophilic perivasculitis and thrombosis. Additional characterization of Pasteurella multocida isolates from these cases was conducted retrospectively from lyophilized cultures. Serogrouping, serotyping, and an enzyme-linked immunosorbent assay (ELISA) for dermonecrotic factor were performed. All isolates were serogroup A or unencapsulated. Serotype 1 was the most prevalent serotype isolated in association with facial cellulitis. ELISA results for dermonecrotic toxin were inconclusive.
This study was designed to develop and characterize a swine pneumonic pasteurellosis model by concurrent introduction of Pasteurella multocida type A and Actinobacillus pleuropneumoniae crude cytotoxin. After a series of preliminary experiments, a combination of 4 x 10(9) P. multocida and 4,000 toxic units of A. pleuropneumoniae crude cytotoxin was determined to produce optimal results. A total of 48 pigs were divided into four groups of 12 pigs each. The control group received buffered saline only. Four pigs from each group were randomly selected for necropsy 3, 7 and 14 days postinoculation (PI). Inoculation of pigs with P. multocida and A. pleuropneumoniae cytotoxin (group 1) resulted in moderate to severe pneumonia. Pasteurella multocida was isolated from pneumonic lesions, grossly normal lung, and bronchial lymph nodes of all group 1 pigs throughout the 14 day experimental period. Pathological changes typical of field cases of swine pneumonic pasteurellosis were produced. Pigs inoculated with P. multocida alone (group 2) had pneumonic lesions and P. multocida was reisolated from lungs at three days PI. Pasteurella multocida was not isolated from these pigs at 7 and 14 days PI, except for one pig in which an abscess developed in the thorax. Pulmonary lesions induced by A. pleuropneumoniae crude cytotoxin alone (group 3) were transient and resolved by seven days PI. Group 1 pigs had significantly greater lung lesion volumes than group 2 and 3 pigs at 3, 7 and 14 days PI. Statistical analysis indicated a significant interactive effect of P. multocida and A. pleuropneumoniae cytotoxin on the development of lung lesion volumes at 7 and 14 days PI (p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
126 Pasteurella (P.) multocida strains isolated from nasal swabs of pigs were investigated for producing toxin, comparing tissue culture (EBL cells) and DAKO ELISA-PMT-Kit. With help of ELISA 13 toxigenic P. multocida strains were identified, with help of tissue culture 12 strains producing toxin. In 14 of 219 examined nasal swab bacteria cultures of pigs toxin of P. multocida was detected by the commercially available ELISA. Because of an abundant mixed bacteria culture in 7 of these 14 swabs suspected colonies of P. multocida could not be isolated.
In bursectomized, cyclophosphamide-treated, and bursectomized/cyclophosphamide-treated turkeys, IgA, IgG, and anti-Pasteurella multocida were determined before and after vaccination with the Clemson University (CU) strain of P. multocida. Before vaccination, the average total serum level of IgA was significantly (P < 0.05) lower in bursectomized and bursectomized/cyclophosphamide-treated turkeys than in untreated controls, and the average serum levels of anti-P. multocida were significantly (P < 0.05) lower in bursectomized, cyclophosphamide-treated, and bursectomized/cyclophosphamide-treated turkeys than in untreated controls. After vaccination, average serum IgA levels were still significantly (P < 0.05) lower in all treated groups of turkeys than in the untreated controls. Also after vaccination, total IgG increased significantly (P < 0.05) only in the bursectomized turkeys, and serum anti-P. multocida antibody levels increased significantly (P < 0.05) in cyclophosphamide-treated, bursectomized/cyclophosphamide-treated, and untreated turkeys. After challenge with virulent P. multocida, survivability was significantly (P < 0.05) lower in the three treated groups of turkeys than in the untreated groups.
Pasteurella multocida serotype 3,4 was isolated from a dead turkey, and the variable nature of its pathogenicity was demonstrated after in vivo passages. The original isolate was encapsulated, and its mean infectious dose (ID50) was higher than 10(8.2) colony-forming units (CFU). To increase virulence, the organism was passaged intravenously in turkeys. After five passages, the encapsulated organism caused 67% mortality with a 10(2) CFU dose, and 50% of the contact control birds also died. A non-encapsulated variant that developed from the original isolate resulted in no mortality, even at a dose as high as 10(9) CFU. After four intratracheal passages, however, the virulence of the non-encapsulated variant increased (ID50 approximately 10(6) CFU), despite no apparent change in its morphological characteristics. These results suggest that both encapsulated and non-encapsulated forms of P. multocida can increase their pathogenicity by bird-to-bird transmission in a short period of time.
One hundred seventy-six cases of fowl cholera were diagnosed at the Georgia Poultry Laboratory over a 3-year period. The disease occurred throughout the year, with peak incidence during March and April. Fowl cholera was diagnosed in flocks from 4 to 83 weeks of age, with a mean of 33 weeks of age. The Pasteurella multocida isolates were highly susceptible to all antimicrobial agents tested, except sulfonamides. The serotypic distribution of isolates showed that serotype 3,4 predominated (40%), followed by serotype 3 (22%), serotype 1 (18%), untypable (15%), serotype 5 (3%), and serotype 4 (2%). Associations were found between the P. multocida serotypes isolated from birds of different ages and between the age of the bird and the sites of choice for isolating the organism.
Explore the source record for details and available documents.
Explore the source record for details and available documents.